Search Constraints
« Previous |
1 - 20 of 29
|
Next »
Search Results
Select an image to start the slideshow
Evaluating the application and limitations of bio-based solvents within organic synthesis
1 of 20
The development of small molecule inhibitors for fibrosis drug discovery
2 of 20
Expedient access to C-aryl linked saturated heterocyclic motifs
3 of 20
The design and synthesis of molecular tools for probing biological function
4 of 20
The development of novel organocatalytic and transition-metal catalysed methodologies for amide bond formation
5 of 20
New methods for the construction of selectively difluorinated carbocycles
6 of 20
Approaches to lead generation for idiopathic pulmonary fibrosis targets
7 of 20
Investigations into the generation and pleiotropic reactivity modes of the nitrile imine 1,3-dipole
8 of 20
Development of novel allosteric regulators of proteinase-activated receptors
9 of 20
The development of natural products as phytotoxic leads for herbicide discovery
10 of 20
Investigation of LPA₁ receptor antagonism / ATX inhibition by a scaffold hopping aproach and SAR analysis
11 of 20
The synthesis and optimisation of toll-like receptor agonists as potential immunomodulatory agents
12 of 20
Structure-guided approaches to the design of novel autotaxin inhibitors
13 of 20
Structure-guided discovery of a novel steroid-derived family of autotaxin inhibitors based on endogenous allosteric modulators
14 of 20
Investigation and application of 3-Oxabicyclo[4.1.0]heptane as a mechanistic target of rapamycin (mTOR) kinase hinge binding fragment
15 of 20
Studies towards the synthesis and labelling of bioactive peptides
16 of 20
The design and synthesis of αvβ6 antagonists and PI3K inhibitors as small molecule therapies for respiratory diseases
17 of 20
The design, synthesis and optimisation of calcium release-activated calcium (CRAC) channel inhibitors and mitochondrial permeability transition pore (mPTP) modulators, using phenotypic screening
18 of 20
Synthesis and evaluation of novel small molecule inhibitors of the androgen receptor amino-terminal domain for the treatment of castration-resistant prostate cancer
19 of 20
Novel approaches targeting phosphoinositide 3-kinase delta
20 of 20